LIMES Schlosskliniken AG, a German operator of high-quality private clinics for mental health, has taken a significant step in its international expansion by signing a notarized preliminary agreement to acquire the operating company of the Villa Boccella estate in Lucca, Tuscany. The agreement was signed on June 17, 2026, in Florence, marking the company's entry into the Italian market.
The Villa Boccella estate is a renovated, luxurious historic property spanning 14 hectares. It comprises eight buildings, including six villas and four swimming pools, with 37 rooms offering 62 beds across a living area of approximately 3,100 square meters. LIMES Schlosskliniken plans to transform the estate into a mental health clinic, primarily targeting an international clientele. The new facility will bridge the gap between Paracelsus Recovery in Zurich and the LIMES locations in Germany, providing a continuum of care for patients seeking treatment for stress-related illnesses, mental and emotional disorders.
LIMES Schlosskliniken has secured an option to purchase the property. The opening of the clinic is planned for early summer 2027, subject to the granting of the clinic license by the relevant authorities. The company's expansion into Italy underscores its commitment to offering a unique, protected, and healing environment for patients, consistent with its relationship-oriented medicine approach.
The LIMES Schlosskliniken Group specializes in treating conditions such as depression, affective disorders, and acute burnout. Its services are aimed at private patients, those entitled to subsidies, and self-payers. The group's philosophy emphasizes top medical quality combined with a holistic recovery environment. Further information about the company can be found at www.limes-schlosskliniken.de.
This acquisition represents a strategic move for LIMES Schlosskliniken, allowing it to extend its reach into Southern Europe and cater to a growing demand for high-end mental health services. The Villa Boccella estate's luxurious amenities and historic charm are expected to attract patients seeking discretion and comfort during treatment. The expansion also reflects a broader trend of healthcare providers investing in premium facilities to differentiate themselves in the competitive mental health market.
With this development, LIMES Schlosskliniken continues to strengthen its position as a leading provider of private mental health care in Europe. The company's stock is listed on the Dusseldorf Open Market, Primary Market, and XETRA under ISIN DE000A0JDBC7 and WKN AOJDBC.
